サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1302477

顔用注射剤市場：タイプ別、エンドユーザー別-2023-2030年の世界予測

Facial Injectables Market by Type, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
顔用注射剤市場：タイプ別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顔用注射剤の世界市場は、2023年に173億米ドル、CAGR 11.69%で大幅な成長が予測され、2030年には377億2,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の顔用注射剤市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.顔用注射剤の世界市場規模および予測は？

2.予測期間中、世界の顔用注射剤市場を形成するCOVID-19の阻害要因と影響は？

3.顔用注射剤の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.顔用注射剤の世界市場における競争戦略は？

5.顔用注射剤の世界市場における技術動向と規制の枠組みは？

6.顔用注射剤の世界市場における主要ベンダーの市場シェアは？

7.顔用注射剤の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 人々の可処分所得の増加と美容処置の需要の増加
      • 世界中の消費者の間で外見への注目が高まっている
      • 人々の間で低侵襲手術への志向が高まる
    • 抑制要因
      • 美容処置をサポートする限定的な償還ポリシー
    • 機会
      • 規制当局の承認を伴う新しい充填剤と老化防止ボツリヌス毒素注射療法のイントロダクション
      • コスメティックツーリズムの台頭
    • 課題
      • 顔面注射製品および関連する副作用に関する厳しい規制上の懸念
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 顔用注射剤市場：タイプ別

  • アンチエイジング注射
    • ボツリヌス毒素A
    • ポリ-L-乳酸（PLLA）微粒子
  • 皮膚充填剤
    • コラーゲンフィラー
    • ヒアルロン酸
    • 合成充填剤

第7章 顔用注射剤市場：エンドユーザー別

  • 美容クリニック
  • 皮膚科クリニック
  • 皮膚科学調査
  • 病院

第8章 南北アメリカの顔用注射剤市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の顔用注射剤市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの顔用注射剤市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. FACIAL INJECTABLES MARKET RESEARCH PROCESS
  • FIGURE 2. FACIAL INJECTABLES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. FACIAL INJECTABLES MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 6. FACIAL INJECTABLES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. FACIAL INJECTABLES MARKET DYNAMICS
  • FIGURE 8. FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. FACIAL INJECTABLES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. FACIAL INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. FACIAL INJECTABLES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. FACIAL INJECTABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 6. FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 10. FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. FACIAL INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 188. FACIAL INJECTABLES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 189. FACIAL INJECTABLES MARKET LICENSE & PRICING
目次
Product Code: MRR-0355054AC48D

The Global Facial Injectables Market is forecasted to grow significantly, with a projected USD 17.30 billion in 2023 at a CAGR of 11.69% and expected to reach a staggering USD 37.72 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Facial Injectables Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Facial Injectables Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers. The Anti-aging Injections commanded largest market share of 52.54% in 2022, followed by Dermal Fillers.

Based on End User, market is studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Hospitals. The Beauty Clinics commanded largest market share of 41.25% in 2022, followed by Dermatology Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.89% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Facial Injectables Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Facial Injectables Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Facial Injectables Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Facial Injectables Market?

4. What is the competitive strategic window for opportunities in the Global Facial Injectables Market?

5. What are the technology trends and regulatory frameworks in the Global Facial Injectables Market?

6. What is the market share of the leading vendors in the Global Facial Injectables Market?

7. What modes and strategic moves are considered suitable for entering the Global Facial Injectables Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Facial Injectables Market, by Type, 2022 vs 2030
  • 4.3. Facial Injectables Market, by End User, 2022 vs 2030
  • 4.4. Facial Injectables Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Disposable Income Among People and Increased Demand for Cosmetic Procedures
      • 5.1.1.2. Increasing Focus on Physical Appearance Among Consumers Globally
      • 5.1.1.3. Rising Inclination Toward Minimally Invasive Procedures Among People
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Reimbursement Policies Supporting Cosmetic Procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of New Fillers and Anti-Aging Botulinum Toxin Injection Therapies coupled with Regulatory Approvals
      • 5.1.3.2. Rise in the Cosmetic Tourism
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Concerns about Facial Injectable Products and Relative Side Effects
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Facial Injectables Market, by Type

  • 6.1. Introduction
  • 6.2. Anti-aging Injections
    • 6.2.1. Botulinum Toxin A
    • 6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
  • 6.3. Dermal Fillers
    • 6.3.1. Collagen Fillers
    • 6.3.2. Hyaluronic Acid
    • 6.3.3. Synthetic Fillers

7. Facial Injectables Market, by End User

  • 7.1. Introduction
  • 7.2. Beauty Clinics
  • 7.3. Dermatology Clinics
  • 7.4. Dermatology Research Institutes
  • 7.5. Hospitals

8. Americas Facial Injectables Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Facial Injectables Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Facial Injectables Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing